Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Kurtz, Jürgen
2003.
A General Investment Agreement in the WTO? Lessons from Chapter 11 of NAFTA and the OECD Multilateral Agreement on Investment.
SSRN Electronic Journal ,
Lawson, Charles
2008.
Accessing and Benefit Sharing the Influenza Viruses: The Sting in the Conflict between the CBD and TRIPS.
SSRN Electronic Journal,
Flynn, Sean M.
2010.
Special 301 of the Trade Act of 1974 and Global Access to Medicines.
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector,
Vol. 7,
Issue. 4,
p.
309.
Basharat, Afshan
2012.
Is TRIPs Friendly to Development?.
SSRN Electronic Journal,
Dolin, Gregory
2012.
Exclusivity Without Patents: The New Frontier of FDA Regulation for Genetic Materials.
SSRN Electronic Journal,
Adusei, Poku
2013.
Patenting of Pharmaceuticals and Development in Sub-Saharan Africa.
p.
29.
Manu, Thaddeus
2014.
Exploring a regional pharmaceutical innovation network as a possible solution to the market failure in the innovation of essential medicines for tropical diseases in sub-Saharan Africa.
African Journal of Science, Technology, Innovation and Development,
Vol. 6,
Issue. 2,
p.
111.
Bird, Robert C.
and
Cahoy, Daniel R.
2014.
Human Rights, Technology, and Food: Coordinating Access and Innovation for 2050 and Beyond.
SSRN Electronic Journal,
Schneider, Giulia
2015.
Conforming Intellectual Property and Privacy Restraints to the Right to Health and the Right to Information in Clinical Trials Data.
SSRN Electronic Journal,
Maxwell, Alice
2019.
Plainly Justifiable? The World Trade Organization’s Ruling on the Validity of Australia’s 'Plain Packaging' Under Article 20 of the TRIPS Agreement.
SSRN Electronic Journal ,
Dos Santos, Fernando
Ncube, Caroline B.
and
Ouma, Marisella
2022.
Intellectual property framework responses to health emergencies – options for Africa.
South African Journal of Science,
Vol. 118,
Issue. 5/6,